Full history for every metric is available with a Kvantra account
ShockWave Medical, Inc. (SWAV)
Key financial summary
Financials in USD| 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | TTM | ||
|---|---|---|---|---|---|---|---|---|
| Total revenue | $m | 12 | 43 | 68 | 237 | 490 | 730 | 788 |
| Operating profit | $m | 166 | 163 | |||||
| Net profit | $m | -41 | -51 | -66 | -9 | 216 | 147 | 163 |
| EPS reported | $ | 3.85 | 4.28 | |||||
| Operating cashflow per share | $ | 5.34 | 5.34 | |||||
| Capex per share | $ | 0.83 | 0.83 | |||||
| FCF per share | $ | 4.51 | 4.51 | |||||
| Free cash flow | $m | 165 | 166 | |||||
| Net debt | $m | -220 | -296 | |||||
| Book value equity | $m | 669 | 752 | |||||
| Book value per share | $ | 17.50 | 19.54 | |||||
| Number of shares | m | 38.21 | 38.47 | |||||
| DPS (TTM paid) | $ | 0.00 | 0.00 |
Financial summary
Financials in USD| 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | TTM | ||
|---|---|---|---|---|---|---|---|---|
| Value | ||||||||
| P/E TTM | x | 49.50 | - | |||||
| P/B LTM | x | 10.46 | 16.72 | |||||
| P/S LTM | x | 9.58 | 15.95 | |||||
| P/FCF LTM | x | 42.27 | 75.65 | |||||
| EV/EBITDA LTM | x | 38.97 | 60.00 | |||||
| EV/Sales LTM | x | 10.18 | 15.57 | |||||
| Earnings Yield LTM | % | 2.02% | 1.20% | |||||
| FCF Yield | % | 2.37% | 1.32% | |||||
| Quality | ||||||||
| ROE | % | 22.03% | 24.96% | |||||
| ROIC | % | 9.57% | 9.57% | |||||
| Operating margin | % | 22.73% | 22.73% | |||||
| Gross margin | % | 86.94% | 86.94% | |||||
| FCF/Sales | % | 22.66% | 22.66% | |||||
| Growth and momentum | ||||||||
| EPS Growth YoY | % | -32.46% | -32.49% | |||||
| Sales Growth YoY | % | +49.11% | +41.42% | |||||
| Net Income Growth YoY | % | -31.81% | -32.05% | |||||
| FCF Growth | % | +78.67% | +37.61% | |||||
| Operating Profit Growth | % | +33.72% | +9.70% | |||||
| Dividend and capital structure | ||||||||
| Dividend Yield | % | 0.00% | 0.00% | |||||
| Dividend Growth | % | 0.00% | 0.00% | |||||
| Payout Ratio | % | 0.00% | 0.00% | |||||
| FCF/Debt | x | 0.21 | 0.21 | |||||
| Net Debt/EBITDA | x | 2.32 | 2.32 | |||||
| EBIT/Net interest | x | 26.79 | 26.79 | |||||
| Net debt/market cap | % | -3.14% | -2.36% | |||||
| Net debt/Equity | x | -0.33 | -0.39 | |||||
| Gross debt/equity | x | 1.15 | 1.03 | |||||
Company overview
ShockWave Medical, Inc. is a medical technology firm that specializes in the development and global commercialization of intravascular lithotripsy (IVL) systems. This innovative approach is designed to treat calcified plaque in individuals affected by peripheral vascular, coronary vascular, and heart valve conditions. The company's product offerings include the M5 catheter for addressing above-the-knee peripheral artery disease, the C2 catheter specifically for coronary artery disease, and the S4 catheter, which targets below-the-knee peripheral artery disease. ShockWave Medical serves a professional clientele, including interventional cardiologists, vascular surgeons, and interventional radiologists, leveraging both direct sales teams and distribution partners. The organization was founded in 2009 and is based in Santa Clara, California.
Similar companies
For informational purposes only. Kvantra provides data and quantitative analysis, not investment advice. KvantraRank is a mechanical model output. Analyst price targets and ratings are sourced from third parties and are not Kvantra recommendations. Past performance does not guarantee future results; all investments carry risk.
ShockWave Medical, Inc. (SWAV)
ShockWave Medical, Inc. is a medical technology firm that specializes in the development and global commercialization of intravascular lithotripsy (IVL) systems. This innovative approach is designed to treat calcified plaque in individuals affected by peripheral vascular, coronary vascular, and heart valve conditions. The company's product offerings include the M5 catheter for addressing above-the-knee peripheral artery disease, the C2 catheter specifically for coronary artery disease, and the S4 catheter, which targets below-the-knee peripheral artery disease. ShockWave Medical serves a professional clientele, including interventional cardiologists, vascular surgeons, and interventional radiologists, leveraging both direct sales teams and distribution partners. The organization was founded in 2009 and is based in Santa Clara, California.
Unlock all fundamental data
Sign up for FreeUnlock all fundamental data
Sign up for Free